Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Andrea Zaenglein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Chronic Morel-Lavallée Lesion in a Pediatric Competitive Dancer: A Case Report and Literature Review
Coakes, C., Axcell, K., Zaenglein, A. L. & Hahn, T., Mar 1 2026, In: Pediatric dermatology. 43, 2, p. 437-440 4 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Connectivity mapping with isotretinoin’s transcriptomic signature identifies alternative therapeutics for severe acne
Sennett, M. L., Feehan, R. P., Wallace, T. E., Gettle, S. L., Longenecker, A. L., Zaenglein, A. L., Thiboutot, D. M. & Nelson, A. M., 2026, (Accepted/In press) In: Journal of Investigative Dermatology.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Scopus citations -
Periorificial Dermatitis, Rosacea, and Idiopathic Aseptic Facial Granuloma in Children
Washington, A., Sanchez, C. & Zaenglein, A. L., 2026, (Accepted/In press) In: Pediatric Clinics of North America.Research output: Contribution to journal › Review article › peer-review
-
A Maximum-Use Trial of Ruxolitinib Cream in Children Aged 2–11 Years with Moderate to Severe Atopic Dermatitis
Stein Gold, L., Bissonnette, R., Forman, S., Zaenglein, A., Kuo, Y. T., Angel, B., Chen, X., Kallender, H. & Paller, A. S., Mar 2025, In: American Journal of Clinical Dermatology. 26, 2, p. 275-289 15 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Link opens in a new tab Scopus citations -
Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study
Eichenfield, L. F., Stein Gold, L. F., Simpson, E. L., Zaenglein, A. L., Armstrong, A. W., Tollefson, M. M., Soong, W., Wine Lee, L., Devani, A. R., Forman, S. B., Siri, D. D., Kallender, H., Angel, B., Li, Q., Chen, X. & Paller, A. S., Sep 2025, In: Journal of the American Academy of Dermatology. 93, 3, p. 689-698 10 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations